Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Miltenyi Biotec launches MACSQuant analyzer
With this instrument launch Miltenyi Biotec broadens the product portfolio of the cell analysis business section and offers customers a milestone flow cytometer with novel features. According to
With this instrument launch Miltenyi Biotec broadens the product portfolio of the cell analysis business section and offers customers a milestone flow cytometer with novel features. According to
Under the terms of the agreement, Circ Pharma will fund the development of the product and IntelGenx will receive royalties from the product’s sales. IntelGenx will use its
It is believed that a majority of the layoffs will include sales representatives and middle managers who comprise one-third of Pfizer’s marketing workforce. Pfizer may also extend its
According to the company, the system was introduced into the Japanese industrial market with a high acceptance due to the improved productivity of their processes and significant savings
In relation to the acquisition of Ranbaxy shares announced in June 2008, and in accordance with the legal requirements in India, Daiichi Sankyo is scheduled to implement an
Edunn’s lead drug candidate, EDN-OL1, is an oligonucleotide-based drug that has shown promise in halting and reversing the progression of Alzheimer’s disease (AD) in animal models. EDN-OLI reduces
In a recent study, ConsumerLab.com evaluated coenzyme Q10 (CoQ10) and ubiquinol products from various nutritional supplement manufacturers to determine whether they contained the amounts of the compounds as
Levetiracetam oral solution, 100 mg/ml is the AB-rated bioequivalent generic to UCB Pharma’s Keppra, 100mg/ml. Cypress’s levetiracetam oral solution, 100mg/ml will be available through all the national drug
Under the agreement, members of Blue Shield of California’s managed care plans will retain access to Tenet’s 13 acute-care hospitals and three freestanding ambulatory surgery centers for their
Mr Fitch is the president and CEO of The Westaim Corporation, Nucryst’s controlling shareholder, holding approximately 75% of Nucryst’s outstanding common shares. Prior to his appointment as president